XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Grant and Awards (Narrative) (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 29, 2022
Jun. 15, 2020
Mar. 13, 2020
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Award [Line Items]                
Revenue from grants       $ 1,225,000 $ 1,338,000 $ 3,001,000 $ 4,457,000  
Medical Technology Enterprise Consortium [Member]                
Award [Line Items]                
Revenue from grants $ 16,300,000 $ 15,000,000.0   1,200,000 1,300,000 3,000,000.0 4,500,000  
Increase in expected revenue from grants $ 1,300,000              
Unbilled award receivable       1,000,000.0   1,000,000.0   $ 1,600,000
Cystic Fibrosis Foundation [Member]                
Award [Line Items]                
Research and development benefit       $ 0 $ 500,000 $ 0 $ 500,000  
Award receivable     $ 1,000,000.0          
Award agreement interruption period     360 days          
Maximum [Member] | Cystic Fibrosis Foundation [Member]                
Award [Line Items]                
Amount of threshold development award     $ 5,000,000.0